Skip to main content
. 2011 Jun 28;286(39):33832–33840. doi: 10.1074/jbc.M110.216564

TABLE 1.

EC50 of various agonists

The dose-response-stimulation (log[agonist] vs. response, non-linear regression) software of Prism 5 (GraphPad Software Inc) was employed to analyze the [35S]GTPγS coupling data and calculate the EC50 values. R-squared values of CHO/GPR31 cells treated with 12-(S)-HETE, 5-(S)-HETE, 15-(S)-HETE, and Hela or HEK293 cells treated with 12-(S)-HETE are: 0.9460, 0.9454, 0.8822, 0.9754, and 0.9840. n, numbers of experimental repeats. Each experiment has four determinations.

Ligands Cell EC50 n
12-(S)-HETE CHO/GPR31 0.28 ± 1.26 (n = 6)
CHO/pcDNA n.s.b.a (n = 2)
12-(R)-HETE CHO/GPR31 n.s.b. (n = 2)
CHO/pcDNA n.s.b. (n = 2)
5-(S)-HETE CHO/GPR31 385.7 ± 62b (n = 2)
CHO/pcDNA n.s.b. (n = 2)
15-(S)-HETE CHO/GPR31 42.1 ± 31b (n = 2)
CHO/pcDNA n.s.b. (n = 2)
12-(S)-HETE Hela/GPR31 0.12 (n = 1)
Hela/pcDNA n.s.b. (n = 1)
12-(S)-HETE HEK293/GPR31 0.11 (n = 1)
HEK293/pcDNA n.s.b. (n = 1)

a n.s.b., no specific binding.

b p < 0.05, vs. 12-(S)-HETE-treated CHO/GPR31 cells, t-test.